Cite
Freeman MP, Viguera AC, Góez-Mogollón L, et al. Correction to: Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Arch Womens Ment Health. 2021;24(4):669-670doi: 10.1007/s00737-021-01133-4.
Freeman, M. P., Viguera, A. C., Góez-Mogollón, L., Young, A. V., Caplin, P. S., McElheny, S. A., Church, T. R., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2021). Correction to: Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Archives of women's mental health, 24(4), 669-670. https://doi.org/10.1007/s00737-021-01133-4
Freeman, Marlene P, et al. "Correction to: Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics." Archives of women's mental health vol. 24,4 (2021): 669-670. doi: https://doi.org/10.1007/s00737-021-01133-4
Freeman MP, Viguera AC, Góez-Mogollón L, Young AV, Caplin PS, McElheny SA, Church TR, Chitayat D, Hernández-Díaz S, Cohen LS. Correction to: Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Arch Womens Ment Health. 2021 Aug;24(4):669-670. doi: 10.1007/s00737-021-01133-4. PMID: 33885978.
Copy
Download .nbib